Synonym: (4R)-3-(5-Oxo-L-prolyl)-1,3-thiazolidine-4-carboxylic acid; (R)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid; (R)-3-[(S)-(5-Oxo-2-pyrrolidinyl) carbonyl]-thiazolidine-4-carboxylic acid; 3-L-Pyroglutamyl-L-thiaziolidine-4carboxylic acid; PGT/1A
CAS Number: 121808-62-6
Empirical Formula (Hill Notation): C9H12N2O4S
Molecular Weight: 244.27
MDL Number: MFCD00867583
Linear Formula: C9H12N2O4S
Product Type: Chemical
| assay |
≥98% (HPLC) |
| color |
white to beige |
| form |
powder |
| InChI |
1S/C9H12N2O4S/c12-7-2-1-5(10-7)8(13)11-4-16-3-6(11)9(14)15/h5-6H,1-4H2,(H,10,12)(H,14,15)/t5-,6-/m0/s1 |
| InChI key |
UUTKICFRNVKFRG-WDSKDSINSA-N |
| optical activity |
[α]/D -135 to -155°, c = 1 in 6 M HCl |
| Quality Level |
100  |
| SMILES string |
OC([C@@H]1CSCN1C([C@H]2NC(CC2)=O)=O)=O |
| solubility |
H2O: 2 mg/mL, clear (warmed) |
| storage temp. |
room temp |
| Biochem/physiol Actions: |
Pidotimod is a dipeptide immunostimulant with biological activity on both the adaptive and the innate immune responses. Pidotimod has been reported to modulate airway epithelial cells functions involved in host-virus interaction possibly through NF-kB activation, promote functional maturation of dendritic cells, and facilitate M2 macrophage polarization and function. Pidotimod has been investigated for use to increase response to recurrent respiratory infections primarily in children. |
| Biochem/physiol Actions: |
Pidotimod is a dipeptide immunostimulant. |
| Packaging: |
50, 250 mg in glass bottle |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥98% (HPLC) |
| Storage Temp. |
room temp |
| UNSPSC |
12352200 |
